Why Should You Attend:
FDA recently issued a final guidance to help industry develop opioid drug products with potentially abuse-deterrent properties. Opioids, as powerful medications, can help manage pain when prescribed and used properly. However, when opioids are used improperly or for recreational purposes, they can cause serious harm, including overdose and death.
It is important for the industry to accurately understand FDA roles and applicable regulation governing controlled substances to adequately achieve compliance. This webinar will help industry get better familiar with FDA regulations and its role including recent opioid drug approvals with abuse-deterrent properties concerning chronic pain management.
At the end of the webinar, attendees will be better aware of FDA regulations, its role, and recent approvals involved in chronic pain management: opioid medications with abuse-deterrent properties.
Areas Covered in the Webinar:
Who Will Benefit:
Dr. David Lim, Ph.D., RAC, ASQ-CQA, is president and principal of Regulatory Doctor. He frequently presents global regulatory and quality compliance topics at various forums and meetings. Recently, Dr. Lim developed 510(k) templates ready for use compliant with e-Copy and RTA policy. In addition, he developed FDA inspection checklists for drug and medical device manufacturers based on his analysis of FDA inspectional observations cited in 483s for the past eight years. Dr. Lim provides his feedback to regulatory agency (e.g., US FDA) through public comments and also served as a panel member during the FDA’s transparency public meeting in 2009.
Dr. Lim contributes to the Regulatory Affairs Professional Society (RAPS) as an author and speaker. He leads and directs all research projects including, but not limited to, pharmacovigilance, medical device reporting, recalls and patient safety signals being conducted at the Regulatory Doctor. He also serves as a member of the Advisory Board for Inspection Insider published by FDA News.
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
PAYMENT METHOD: 100% Secure Transaction